Imunon IMNN
NASDAQ IMNN
$1.32 +0.03 (+2.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Imunon (IMNN) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Imunon's Liabilities and Shareholders Equity was $8.02 million in Q1 2026, up 16.9% from $6.86 million a year earlier but down 34.7% from the prior quarter.

Analysis

Imunon (IMNN) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Imunon came in at $12.29 million, up 26.5% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -20.0% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $9.72 million in FY2024 (-55.7%), $21.92 million in FY2023 (-50.2%), $43.98 million in FY2022 (-40.6%) and $74.05 million in FY2021 (+97.3%).
  • Quarterly Liabilities and Shareholders Equity has moved between $6.86 million (Q1 2025) and $83.01 million (Q2 2021) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in two of the last six quarters, with an average decline of 23.3%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2021 (growth of 113.2%); the worst was Q2 2024 (a decline of 66.3%).
  • Per Business Quant data, IMNN's Liabilities and Shareholders Equity in the three quarters before Q1 2026 was $12.29 million (Q4 2025), $8.99 million (Q3 2025) and $8.79 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Imunon 6.02 Mn 6.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 8.02 Mn
Dec 31, 2025 12.29 Mn
Sep 30, 2025 8.99 Mn
Jun 30, 2025 8.79 Mn
Mar 31, 2025 6.86 Mn
Dec 31, 2024 9.72 Mn
Jun 30, 2024 9.69 Mn
Mar 31, 2024 14.32 Mn
Dec 31, 2023 21.92 Mn
Sep 30, 2023 24.65 Mn
Jun 30, 2023 28.72 Mn
Mar 31, 2023 42.11 Mn
Dec 31, 2022 43.98 Mn
Sep 30, 2022 60.53 Mn
Jun 30, 2022 65.33 Mn
Mar 31, 2022 64.34 Mn
Dec 31, 2021 74.05 Mn
Sep 30, 2021 79.47 Mn
Jun 30, 2021 83.01 Mn
Mar 31, 2021 73.04 Mn
API Access

Imunon Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=IMNN&period=max&api_key=YOUR_API_KEY